Research Peptide SKU: EU-CAGRILIN

Cagrilintide

≥98% Purity Class-level spec; selected lots third-party tested
COA Available Batch report on request · HPLC identity check
Size 10mg = Lab report published

€39.99

1

Total: €39.99

Unavailable

Free shipping on orders over €200

  • If a product does not match the specification on its published COA, contact us with your batch number: we investigate against the lot report and replace any product that fails it, at no cost to you.
  • Contact us within 48 hours of delivery with photos of the outer box, inner packing, and any affected vials with labels legible. Confirmed transit damage is replaced at no cost to you.

3–7 days most of the EU · 10–14 Nordics/Baltics

Standard EU from €4.99 · core EU GLS €17.99 · Dispatched within 1–2 business days · Free shipping over €200 · no customs paperwork (EU).

How Paysera and SEPA work

  1. Pay: send a manual SEPA transfer using the IBAN we email you, or approve a SEPA transfer via Paysera where offered.
  2. We confirm — Paysera notifies us instantly, or we match a manual transfer when it arrives (usually 1 business day).
  3. We dispatch — confirmed orders typically ship within 1–2 business days.

Card payments are not currently offered.

Research-grade Cagrilintide peptide for laboratory and analytical research. High purity. For research purposes only. Not for human consumption.

Volume Pricing Applied automatically at checkout
Quantity Price Each Total Savings
1 unit €39.99 €39.99 —
3+ €37.99 €113.97 5% off
10+ €33.99 €339.92 15% off
Published reports

Laboratory reports are available for selected lots. Check each report for its result and stated method.

Third-Party Tested

Class-level specification on record; independent testing on selected lots.

Fast Shipping

Dispatched within 1–2 business days, shipping from €4.99 in the EU.

EU Dispatch

Ships across the EU plus Switzerland and the UK where permitted.

Last reviewed: 2026-11-03

Cagrilintide 5mg Peptide

Cagrilintide is a long-acting amylin analogue for weight management and improved glucose control in obesity and type 2 diabetes. It suppresses appetite, slows gastric emptying, reduces post-meal glucose excursions, and can enhance weight loss when combined with GLP-1 therapies. Investigational once-weekly formulations may improve adherence.

What is Cagrilintide 5mg

Cagrilintide 5mg is a long-acting synthetic amylin analogue, supplied as a lyophilised powder for laboratory research only. It is not a medicine and is not for human or veterinary administration.

Cagrilintide, also coded AM833, is an acylated analogue of amylin. The fatty-acid modification is intended to promote albumin binding and extend exposure in the models where that has been studied. It acts through calcitonin-receptor/RAMP complexes, not through the GLP-1 receptor. Published work has examined it alone and with semaglutide, including the combination studied as CagriSema. Those findings do not transfer to this vial, and they are not a dosing guide.

Product Cagrilintide 5mg
Also known as AM833
Class Long-acting acylated amylin analogue
Format Lyophilised powder, single sealed vial
Documentation Batch certificate of analysis, with HPLC purity and the method used. Identity should be stated on the same certificate.
Storage As stated on the vial label. Protect the sealed vial from light and moisture.
Intended use Laboratory research only
 
 

Handling

Check the lot number against the certificate before the material enters an assay. Reconstitute only when the protocol calls for a working solution, using the solvent and concentration that protocol specifies. A prepared solution needs its own stability limit. Do not take that limit from the dry vial or from a clinical-trial schedule.

EU orders should be checked for the 5mg pack size, dispatch timing, and the certificate supplied with the vial.

For research use only. Not for human or animal administration.

Related studies: